Compared with the patients assigned as low-risk, the high-risk patient group showed that the top two enriched pathways were cell cycle (Fig. 5c) and PLK signaling (Fig. 5d), which both play critical roles in cancer initiation and development. This evidence concerns the gene PLK1 and cancer.